Changing oral vaccine to inactivated polio vaccine might increase mortality.

Fish EN.; Flanagan KL.; Furman D.; Klein SL.; Kollmann TR.; Jeppesen DL.; Levy O.; Marchant A.; Namachivayam S.; Netea MG.; Plebanski M.; Rowland-Jones SL.; Selin LK.; Shann F.; Whittle HC.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Fish EN., Flanagan KL., Furman D., Klein SL., Kollmann TR., Jeppesen DL., Levy O., Marchant A., Namachivayam S., Netea MG., Plebanski M., Rowland-Jones SL., Selin LK., Shann F., Whittle HC.

Original publication

DOI

10.1016/s0140-6736(16)00661-9

Type

Journal article

Journal

Lancet (London, England)

Publication Date

03/2016

Volume

387

Pages

1054 - 1055

Addresses

Toronto General Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: en.fish@utoronto.ca.

Keywords

Humans, Poliomyelitis, Poliovirus Vaccine, Inactivated, Poliovirus Vaccine, Oral, Female, Male, Drug Substitution